Kabra Drugs Ltd.
Fundamentals
- Market cap
- ₹57.37 cr
- P/E
- 13.35×
- ROE
- 0.00%
- Debt / equity
- 0.02
- 52-week range
- 11.63 — 35.52
The timeline — 2 notes on Kabra Drugs Ltd.
May 2026
- 29 May 26 · 10:21 PM IST Brief Brief · Earnings · Micro cap
Kabra Drugs books ₹92.74 cr revenue after a year of zero sales
The nano-cap swung to a ₹4.96 cr profit after diversifying into new manufacturing. The full-year revenue now exceeds the company's entire market capitalisation.
- 29 May 26 · 8:35 PM IST Brief Brief · Earnings · Micro cap
Kabra Drugs posts ₹92.74 cr revenue after a year of nil sales
The nano-cap drugmaker executed a new manufacturing strategy, swinging from a ₹1.08 cr loss to a ₹4.96 cr profit on a ₹92.74 cr topline.